AUSTIN, Minn. – A team led by a Hormel Institute researcher is getting $1.8 million to study a rare premature aging disease in children. The money is coming from the Center for Biologics Evaluation and Research of the Food and Drug Administration and will be given out over a three-year period. There are currently no treatments for the ultra-rare disorder that causes accelerated aging, short stature, photosensitivity, neurological dysfunction, liver and kidney damage, and digestive problems.
-0-